Hanjin Xiong

Hanjin (Alec) Xiong is a seasoned professional in the healthcare industry currently serving as Vice President at Legend Capital since November 2017, following a role as Investment Analyst at MSQ Ventures from October 2016 to September 2017. Earlier experience includes a position as Graduate Research Assistant at the National Institutes of Health, where Hanjin contributed to the project "Photoactivatable Nanoparticles for Targeted Drug Delivery." Hanjin also excelled as Project Lead at the National Laboratory for Physical Sciences at the Microscale, earning a Gold Medal in the World Championship of IGEM at MIT for research on needleless vaccines. Academic credentials include a Master of Science in Healthcare Management from The Johns Hopkins University and a Bachelor of Science in Biochemistry from the University of Science and Technology of China.